Protection of Tanshinone IIA to human peritoneal mesothelial cells (HPMC) through delaying cellular senescence induced by high glucose

Renal Failure

Volumn 34, Issue 1, 2012, Pages 88-94

  Cao, Dongwei ^a   Zhang, Miao ^a   Jiang, Chunming ^a   Xue, Lina ^a   Sun, Cheng ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Cellular senescence; High glucose; Human peritoneal mesothelial cells; Peritoneal fibrosis; Tanshinone IIA

Indexed keywords

BETA GALACTOSIDASE; GLUCOSE; PROTEIN P16; PROTEIN P21; TANSHINONE IIA;

ARTICLE; CELL AGING; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESISTANCE; HUMAN; HUMAN CELL; HUMAN PERITONEAL MESOTHELIAL CELL; MESOTHELIUM CELL; PERITONEAL FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; TELOMERE; WESTERN BLOTTING;

CELL AGING; CELLS, CULTURED; DITERPENES, ABIETANE; EPITHELIAL CELLS; GLUCOSE; HUMANS; PERITONEUM; TIME FACTORS;

EID: 84055199557     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.623497     Document Type: Article

References (27)

1. Witowski J, Wisniewska J, Korybalska K, et al. Prolonged exposure high glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol. 2001;12:2434-2441. (Pubitemid 33021121)
2. Hung KY, Huang JW, Tsai TJ, et al. Peritoneal fibrosing syndrome: Pathogenetic mechanism and current therapeutic strategies. J Chin Med Assoc. 2005;68(9):401-405.
3. Leavesley DI, Stanley JM, Faull RJ. Epidermal growth factor modifies the expression and function of extracellular matrix adhesion receptors expressed by peritoneal mesothelial cells from patients on CAPD. Nephrol Dial Transplant. 1999; 14:1208.
4. Gotloib L, Shostak A, Wajsbist V, et al. High glucose induced a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron. 1999;82(1):164.
5. Shostak A, Wajsbrot V, Gotloib L. High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int. 2000;58(5):2044-2052.
6. Ksiazek K, Korybalska K, Jörres A, et al. Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: The role of TGF-beta1. Lab Invest. 2007;87(4): 345-356. (Pubitemid 46474562)
7. Ksiazek K, Breborowicz A, Jörres A, et al. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med. 2007;42(5):636-641. (Pubitemid 46205146)
8. Liu T, Jin H, Sun QR, Xu JH, Hu HT. The neuroprotective effects of tanshinone IIA on beta-amyloid-induced toxicity in rat cortical neurons. Neuropharmacology. 2010;59:595-604.
9. Yang L, Zou XJ, Gao X, et al. Sodium tanshinone IIA sulfonate attenuates angiotensin II-induced collagen type I expression in cardiac fibroblasts in vitro. Exp Mol Med. 2009;41: 508-516.
10. Li YI, Elmer G, Leboeuf RC. Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase. Life Sci. 2008;83: 557-562.
11. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P. Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis. Eur J Pharmacol. 2007;568:213-221. (Pubitemid 46976900)
12. Tang F, Wu X, Wang T, et al. Tanshinone IIA attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol. 2007;46:427-438. (Pubitemid 46552282)
13. Chunming J, Miao Z, Cheng S, et al. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model. Ren Fail. 2011;33(3):355-362.
14. Stylianou E, Jenner LA, Davies M, et al. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int. 1990;37(6):1563-1570. (Pubitemid 20198041)
15. Zhang XY, Pettengell R, Nasiri N, Kalia V, Dalgleish AG, Barton DP. Characteristics and growth patterns of human peritoneal mesothelial cells: Comparison between advancedepithelial ovarian cancer and non-ovarian cancer sources. J Soc Gynecol Investig. 1999;6:333-340. (Pubitemid 30009767)
16. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990;345(6274):458-460.
17. Fischereder M, Luckow B, Sitter T, Schroppel B, Banas B, Schlondorff D. Immortalization and characterization of human peritoneal mesothelial cells. Kidney Int. 1997;51:2006-2012. (Pubitemid 27252775)
18. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-9367.
19. Chen X, Cao D, Wang J, et al. Effects of human Na(+)/dicarboxylate cotransporter 3 on the replicative senescence of human embryonic lung diploid fibroblasts. J Gerontol A Biol Sci Med Sci. 2005;60(6):709-714. (Pubitemid 40881176)
20. Harley CB, Futcher AB, Greider CW. Telomeres shorten during aging of human fibroblast. Nature. 1990;345: 458-460.
21. von Zglinicki V, Pilger R, Sitte N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med. 2000;28(1):24-27.
22. Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp Gerontol. 2000;35(8):927-945.
23. Fang J, Xu SW, Wang P, et al. Tanshinone IIA attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. Phytomedicine. 2010;18:58-64.
24. Sun RF, Liu LX, Zhang HY. Effect of Tanshinone II on hepatic fibrosis in mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009;29:1012-1017.
25. Tang J, Zhan C, Zhou J. Effects of Tanshinone IIA on transforming growth factor beta 1-Smads signal pathway in renal interstitial fibroblasts of rats. J Huazhong Univ Sci Technol Med Sci. 2008;28:539-542.
26. Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev. 2007;27:133-148. (Pubitemid 44975189)
27. Zhou L, Zuo Z, Chow MS. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol. 2005;45:1345-1359. (Pubitemid 41643896)